Effect of octreotide on stimulated insulin release from pancreatic tissue slices

Pancreas

Volumn 16, Issue 2, 1998, Pages 141-147

  Presti, Michael E ^a   Burton, Frank R ^a   Niehoff, Michael L ^a   Rioux, John ^a   Garvin, Paul J ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

Canine; Endocrine; In vitro; Octreotide acetate; Pancreas

Indexed keywords

AMYLASE; CHOLECYSTOKININ OCTAPEPTIDE; GLUCAGON; GLUCOSE; INSULIN; OCTREOTIDE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; FEMALE; INSULIN RELEASE; NONHUMAN; PANCREAS SECRETION; PRIORITY JOURNAL; TISSUE SLICE;

EID: 0031882493     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199803000-00006     Document Type: Article

References (32)

1. Misumi A, Shiratori K, Lee KY, Barkin JS, Chey WY. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs. Surgery 1988;103: 450-5.
2. Lembcke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 1987;36:108-24.
3. Arnold R, Lankisch PG. Somatostatin and the gastrointestinal tract. Clin Gastroenterol 1980;9:733-53.
4. Garvin PJ, Burton FR, Reese JC, Lingle D, Pandya PK. Niehoff ML. The effect of octreotide acetate on meal-stimulated exocrine secretion in canine pancreatic autografts. Transplantation 1991;52: 453-7.
5. Basadonna G, Fox U, Ribaldone G, et al. The use of MS 201-995, a somatostatin analog in pancreas transplantation. Transplant Proc 1990;22:602-3.
6. Rosenberg L, Datoe DC, Schwartz R, Campbell DA. Administration of somatostatin analog (SMS 201-995) in the treatment of a fistula occurring after pancreas transplantation. Transplantation 1987;43:764-6.
7. Cooper MM, Wright FH, Smith JL, Corry RJ. Successful treatment of a high output fistula with a somatostatin analogue following pancreas transplantation. Transplant Proc 1989;21:3738-41.
8. Landgraf R, Landgraf-Leurs MMC, Nusser J, et al. Effect of somatostatin analogue (SMS 201-995) on cyclosporin levels. Transplantation 1987;43:724-5.
9. Secchi A, DiCarlo V, Martinenghi S, et al. Octreotide administration in the treatment of pancreatic fistulae after pancreas transplantation. Transplant Int 1992;5:201-1.
10. Stratta RJ, Taylor RJ, Lowell JA, et al. Selective use of sandostatin in vascularized pancreas transplantation. Am J Surg 1993;166:598-605.
11. Presti M, Niehoff M, Rioux J, Burton F, Garvin P. The effect of octreotide acetate on pancreatic endocrine function following partial pancreatectomy. J Surg Res 1996;61:449-53.
12. National Research Council. Guide for the care and use of laboratory animals. NIH Publication No. 86-23, 1985.
13. Krebs HA. Body size and tissue respiration. Biochim Biophys Acta 1950;4:249-69.
14. Hales CN, Milner RDG. The role of sodium and potassium in insulin secretion from rabbit pancreas. J Physiol 1968;194:725-43.
15. Milner RDG, Hales CN. The interaction of various inhibitors and stimuli of insulin release studied with rabbit pancreas in vitro. Biochem J 1969;113:473-9.
16. Garvin PJ, Niehoff M, Burton F. The effect of terbutaline on exocrine function in the denervated canine pancreas. Transplantation 1988;46:739-43.
17. Stadie WC, Riggs BC. Microtome for the preparation of tissue slices for metabolic studies of surviving tissues in vitro. J Biol Chem 1944;154:687-90.
18. Grossman I, Simon D. Potential gastrointestinal uses of somato-statin and its synthetic analogue octreotide. Am J Gastroenterol 1990;85:1061-72.
19. Tydèn G, Brattström C, Häggmark A, Groth CG. Studies on the exocrine secretion of segmental pancreatic grafts in humans. Surg Gynecol Obstet 1987;164:404-8.
20. Pederzoli P, Basi C, Falconi M, Camboni MG. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Br J Surg 1994;81:265-9.
21. Matsushita K, Okabayashi Y, Hasegawa H, et al. In vitro inhibitory effect of somatostatin on secretin action in exocrine pancreas of rats. Gastroenterology 1993;104:1146-52.
22. Goto Y, Garcia R, Debas HT. Inhibitory pancreatic neurons mediate the inhibitory action of somatostatin on pancreatic exocrine secretion. Gastroenterology 1987;92:1410.
23. Konturek SJ, Bilski J, Jaworek J, Tasler J, Schalby AV. Comparison of somatostatin and its highly potent hexa- and octapeptide analogs on exocrine and endocrine pancreatic secretion. Proc Soc Exp Biol Med 1988;187:241-9.
24. Muller MK, Kessell B, Hütt T, Kath R, Layer P, Goebell H. Effects of somatostatin-14 on gastric and pancreatic responses to hormonal and neural stimulation using an isolated perfused rat stomach and pancreas preparation. Pancreas 1988;3:303-10.
25. Singh M. Effect of somatostatin on amylase secretion from in vivo and in vitro rat pancrease. Dig Dis Sci 1986;31:506-12.
26. Esteve JP, Vaysse C, Susini J, et al. Binodal regulation of pancreatic exocrine function in vitro by somatostatin-28. Am J Physiol 1983;245:G208-16.
27. Wachter M, Hotz J, Cherian L, Goebell H. Failure of somatostatin to inhibit pancreatic enzyme secretion in vitro. Gastroenterol Biol 1978;3:303.
28. Albinus M, Blair EL, Case RM, et al. Comparison of the effect of somatostatin on gastrointestinal function in the conscious and anaesthetized cat and on the isolated cat pancreas. J Physiol 1977; 269:77-91.
29. Albano JDM. Bhoola KD, Harvey RF. Effects of cholecystokinin and somatostatin on pancreatic enzyme secretion and tissue levels of cyclic GMP and cyclic AMP. Ir J Med Sci 1977;146:21-2.
30. Hurst RD, Morgan NG. Intracellular events responsible for the inhibition of insulin secretion by somatostatin. Biochem Soc Trans 1989;17:1085-6.
31. Fujimoto WY, Ensick JW, Williams RH. Somatostatin inhibits insulin and glucagon release by monolayer cell cultures of rat endocrine/pancreas. Life Sci 1975;15:1999-2004.
32. Parmar H, Phillips RH, Lightman SL. Somatostatin analogues: mechanisms of action. Recent Results Cancer Res 1993;129:1-24.